Key Points
- CRO John Anthony Dibella II sold 1,000 shares of Simulations Plus on April 15 at an average price of $13.37 under a pre-arranged Rule 10b5-1 plan, cutting his stake by 1.11% to 89,140 shares valued at roughly $1.19 million.
- Simulations Plus beat quarterly estimates with EPS of $0.35 and revenue of $24.29 million, but still reported a negative net margin (~77.96%) and a stock trading near its 50-day and 200-day moving averages ($12.36 and $15.93).
- Several recent analyst downgrades and a lower price target have left the stock with a consensus rating of 'Hold' and an average target price of $24.40.
Simulations Plus, Inc. (NASDAQ:SLP - Get Free Report) CRO John Anthony Dibella II sold 1,000 shares of Simulations Plus stock in a transaction that occurred on Wednesday, April 15th. The shares were sold at an average price of $13.37, for a total value of $13,370.00. Following the completion of the transaction, the executive owned 89,140 shares in the company, valued at $1,191,801.80. This trade represents a 1.11% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Simulations Plus Price Performance
Simulations Plus stock opened at $14.12 on Friday. The business has a 50 day simple moving average of $12.36 and a 200-day simple moving average of $15.93. Simulations Plus, Inc. has a 12 month low of $11.09 and a 12 month high of $36.45. The stock has a market capitalization of $285.22 million, a PE ratio of -4.51 and a beta of 1.19.
Simulations Plus (NASDAQ:SLP - Get Free Report) last posted its quarterly earnings data on Thursday, April 9th. The technology company reported $0.35 earnings per share for the quarter, beating analysts' consensus estimates of $0.27 by $0.08. The firm had revenue of $24.29 million for the quarter, compared to analyst estimates of $21.66 million. Simulations Plus had a negative net margin of 77.96% and a positive return on equity of 16.21%. As a group, equities research analysts anticipate that Simulations Plus, Inc. will post 1.09 EPS for the current year.
Analyst Ratings Changes
SLP has been the subject of a number of recent analyst reports. Wall Street Zen downgraded shares of Simulations Plus from a "buy" rating to a "hold" rating in a research report on Saturday, April 4th. BTIG Research downgraded Simulations Plus from a "buy" rating to a "neutral" rating in a research note on Thursday, December 18th. TD Cowen reduced their price target on Simulations Plus from $19.00 to $16.00 and set a "hold" rating for the company in a report on Friday, April 10th. Zacks Research downgraded Simulations Plus from a "strong-buy" rating to a "hold" rating in a research note on Monday, February 2nd. Finally, Citigroup restated a "market perform" rating on shares of Simulations Plus in a research report on Tuesday, January 6th. Three research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of "Hold" and an average target price of $24.40.
Check Out Our Latest Research Report on Simulations Plus
Hedge Funds Weigh In On Simulations Plus
Several hedge funds and other institutional investors have recently bought and sold shares of SLP. First Light Asset Management LLC boosted its position in Simulations Plus by 156.4% during the fourth quarter. First Light Asset Management LLC now owns 1,968,917 shares of the technology company's stock worth $35,893,000 after purchasing an additional 1,201,157 shares in the last quarter. Tributary Capital Management LLC increased its position in shares of Simulations Plus by 214.7% in the third quarter. Tributary Capital Management LLC now owns 1,136,980 shares of the technology company's stock valued at $17,134,000 after buying an additional 775,704 shares in the last quarter. Ameriprise Financial Inc. raised its stake in shares of Simulations Plus by 25.3% during the 2nd quarter. Ameriprise Financial Inc. now owns 875,447 shares of the technology company's stock worth $15,277,000 after buying an additional 176,747 shares during the last quarter. Marshall Wace LLP boosted its position in shares of Simulations Plus by 127.5% in the 4th quarter. Marshall Wace LLP now owns 569,783 shares of the technology company's stock worth $10,387,000 after buying an additional 319,301 shares in the last quarter. Finally, Stephens Investment Management Group LLC boosted its position in shares of Simulations Plus by 30.8% in the 4th quarter. Stephens Investment Management Group LLC now owns 513,728 shares of the technology company's stock worth $9,365,000 after buying an additional 120,888 shares in the last quarter. 78.08% of the stock is owned by institutional investors and hedge funds.
Simulations Plus Company Profile
(
Get Free Report)
Simulations Plus, Inc (NASDAQ: SLP) specializes in advanced modeling and simulation software tailored to the pharmaceutical, biotechnology and chemical industries. The company's flagship products include ADMET Predictor, a quantitative structure-activity relationship (QSAR) tool for predicting absorption, distribution, metabolism, excretion and toxicity properties, and GastroPlus, a physiologically based pharmacokinetic (PBPK) modeling platform for simulating drug absorption and pharmacokinetics.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
